Bellini duct carcinoma

(redirected from tubulocystic carcinoma)

collecting duct carcinoma of the kidney

an aggressive form of renal carcinoma, presumably originating from collecting ducts.

Bellini duct carcinoma

An uncommon type of kidney cancer (1–3%) which arises in the duct of Bellini of the kidney, which was underdiagnosed in the past as renal cell carcinoma (RCC) or a subtype of RCC. In contrast to common varieties of RCs, Bellini duct carcinoma (BDC) does not respond well to the chemotherapy used for RCC and is more aggressive, with one small series reporting a 2-year survival of 20%.
References in periodicals archive ?
Tubulocystic carcinoma of the kidney: Clinicopathological analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma.
Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: Implications for pathologic classification.
Tubulocystic carcinoma of the kidney with poorly differentiated foci: A series of 3 cases with fluorescence in situ hybridization analysis.
Is tubulocystic carcinoma with dedifferentiation a form of hlrcc/ fumarate hydratase-deficient rcc?
Tubulocystic carcinoma (TCC) of the kidney is an exceedingly rare, recently recognized subtype of renal cell carcinoma, with <100 cases reported in the literature.
Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma.
Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors.
Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney.
Tubulocystic carcinoma of the kidney is a well-circumscribed tumor with pure tubular and cystic growth patterns, cysts and tubules lined by a single layer of atypical cells with abundant eosinophilic cytoplasm and a variable hobnail appearance, and stromal desmoplasia (Figure 9).
dagger]) Tubulocystic carcinoma is a distinct low-grade variant of renal cell carcinoma that was not listed in the 2004 WHO classification.
Tubulocystic carcinoma of the kidney, clinicopathologic and molecular characterization.
63) It is now recognized that AMACR can show positivity in tumors from many different organs and in several different types of renal tumors, including most MiTF/TFE family translocation carcinomas, tubulocystic carcinomas, some collecting duct carcinomas, most mucinous tubular and spindle cell carcinomas, most acquired cystic disease-associated renal cell carcinomas, and some high-grade urothelial carcinomas of the renal pelvis.